Beyond Cannabis: Plants and the Endocannabinoid System

Trends in Pharmacological Sciences

Volumn 37, Issue 7, 2016, Pages 594-605

  Russo, Ethan B ^a  

^a PHYTECS   (United States)

Author keywords

cannabidiol; cannabinoids; endocannabinoid system; ethnobotany; phytotherapy; tetrahydrocannabinol

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACYLGLYCEROL LIPASE; AMIDE; ANANDAMIDE; CANNABIDIOL; CANNABIGEROL; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABIS; CAPSAICIN; CARYOPHYLLENE; CURCUMIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FATTY ACID AMIDASE; GINGEROL; KAEMPFEROL; PANAXYNOL; PERROTTETINENE; PERROTTETINENIC ACID; PIPERINE; PREBIOTIC AGENT; PROBIOTIC AGENT; RESINIFERATOXIN; SALVINORIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; YANGONIN; AMIDASE; CANNABINOID; ENDOCANNABINOID; FATTY-ACID AMIDE HYDROLASE; SESQUITERPENE; TRPV1 RECEPTOR; VANILLOID RECEPTOR;

BLACK PEPPER; BOSWELLIA SACRA; CACAO; CAMELLIA SINENSIS; CARROT; COMMON COLD; CURCUMA LONGA; DRUG STRUCTURE; FOOD; GINGER; HERB; HOMEOSTASIS; HUMAN; IRRITABLE COLON; LEPIDIUM; LEPIDIUM MEYENII; LIVERWORT; MEDICAL LITERATURE; NONHUMAN; PEPPER; PHYTOCHEMISTRY; PIPER METHYSTICUM; PLANT; PRIORITY JOURNAL; REVIEW; SPICE; TRADITIONAL HEALER; AGONISTS; ANTAGONISTS AND INHIBITORS; CHEMISTRY; MEDICINAL PLANT; PHYSIOLOGY; PHYTOTHERAPY;

AMIDOHYDROLASES; CANNABINOIDS; CANNABIS; ENDOCANNABINOIDS; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; PROBIOTICS; SESQUITERPENES; TRPV CATION CHANNELS;

EID: 84969932209     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2016.04.005     Document Type: Review

References (81)

1. P. Pacher, and G. Kunos Modulating the endocannabinoid system in human health and disease-successes and failures FEBS J. 280 2013 1918 1943
2. E.B. Russo, and et al. Current status and future of cannabis research Clin. Res. 2015 58 63 April
3. M. Maccarrone, and et al. Endocannabinoid signaling at the periphery: 50 years after THC Trends Pharmacol. Sci. 36 2015 277 296
4. J.M. McPartland, and et al. Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system PLoS ONE 9 2014 e89566
5. E.B. Russo Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuroendocrinol. Lett. 25 2004 31 39
6. W.A. Devane, and et al. Determination and characterization of a cannabinoid receptor in rat brain Mol. Pharmacol. 34 1988 605 613
7. M. Glass, and et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain Neuroscience 77 1997 299 318
8. V. Di Marzo 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance Biochim. Biophys. Acta 1392 1998 153 175
9. F. Taura, and et al. Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes Chem. Biodivers. 4 2007 1649 1663
10. B. Zirpel, and et al. Production of Delta9-tetrahydrocannabinolic acid from cannabigerolic acid by whole cells of Pichia (Komagataella) pastoris expressing Delta9-tetrahydrocannabinolic acid synthase from Cannabis sativa L Biotechnol. Lett. 37 2015 1869 1875
11. D.J. Siebert Salvia divinorum and salvinorin A: new pharmacologic findings J. Ethnopharmacol. 43 1994 53 56
12. E. Russo, and et al. In search of plants, other than Cannabis sativa, with cannabinoid receptor activity In Symposium on the Cannabinoids International Cannabinoid Research Society 2002 pp. 46
13. B.L. Roth, and et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist Proc. Natl. Acad. Sci. U.S.A. 99 2002 11934 11939
14. R. Capasso, and et al. Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors Br. J. Pharmacol. 155 2008 681 689
15. J. Fichna, and et al. Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors Neurogastroenterol. Motil. 21 2009 1326-e1128
16. M. Leonti, and et al. Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin Biochem. Pharmacol. 79 2010 1815 1826
17. V. Lebot, and et al. Kava-The Pacific Elixir: The Definitive Guide to its Ethnobotany, History, and Chemistry 1997 Healing Arts Press
18. E.B. Russo Handbook of Psychotropic Herbs: A Scientific Analysis of Herbal Remedies for Psychiatric Conditions 2001 Haworth Press
19. 1 receptor ligand Pharmacol. Res. 66 2012 163 169
20. D. Wu, and et al. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots Phytomedicine 9 2002 41 47
21. M. Toyota, and et al. Bibenzyl cannabinoid and bisbibenzyl derivative from the liverwort Radula perrottetii Phytochemistry 37 1994 859 862
22. M. Toyota, and et al. New bibenzyl cannabinoid from the New Zealand liverwort Radula marginata Chem. Pharm. Bull. 50 2002 1390 1392
23. Z. Hajdu, and et al. Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii J. Nat. Prod. 77 2014 1663 1669
24. 2 receptor agonists in vitro Br. J. Pharmacol. 150 2007 613 623
25. R.B. Laprairie, and et al. Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor Br. J. Pharmacol. 172 2015 4790 4805
26. M. Styrczewska, and et al. Cannabinoid-like anti-inflammatory compounds from flax fiber Cell. Mol. Biol. Lett. 17 2012 479 499
27. E.B. Russo Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects Br. J. Pharmacol. 163 2011 1344 1364
28. T. Bisogno, and et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide Br. J. Pharmacol. 134 2001 845 852
29. E. Russo Cannabidiol and TRPV1: turning down the heat (and pain) 6th Conference on Cannabis in Medicine International Association for Cannabinoid Medicines 2011 pp. 35
30. P. Seephonkai, and et al. Ferruginenes A-C from Rhododendron ferrugineum and their cytotoxic evaluation J. Nat. Prod. 74 2011 712 717
31. I. Kissin, and A. Szallasi Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials Curr. Top. Med. Chem. 11 2011 2159 2170
32. A. Szallasi, and P.M. Blumberg Vanilloid (Capsaicin) receptors and mechanisms Pharmacol. Rev. 51 1999 159 212
33. E. Palazzo, and et al. Moving towards supraspinal TRPV1 receptors for chronic pain relief Mol. Pain 6 2010 66
34. S.P. Banerjee, and et al. Cannabinoids: influence on neurotransmitter uptake in rat brain synaptosomes J. Pharmacol. Exp. Ther. 194 1975 74 81
35. R.E. Musty, and R.A. Deyo A cannabigerol extract alters behavioral despair in an animal model of depression Symposium on the Cannabinoids 2006 International Cannabinoid Research Society pp. 32
36. A. Ligresti, and et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma J. Pharmacol. Exp. Ther. 318 2006 1375 1387
37. J.D. Wilkinson, and E.M. Williamson Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis J. Dermatol. Sci. 45 2007 87 92
38. G. Appendino, and et al. Antibacterial cannabinoids from Cannabis sativa: a structure-activity study J. Nat. Prod. 71 2008 1427 1430
39. M.G. Cascio, and et al. Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist Br. J. Pharmacol. 159 2010 129 141
40. L. De Petrocellis, and et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes Br. J. Pharmacol. 163 2011 1479 1494
41. L. De Petrocellis, and V. Di Marzo Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels J. Neuroimmune Pharmacol. 5 2010 103 121
42. F. Bohlmann, and E. Hoffmann Cannabigerol-Ahnliche Verbindungen aus Helichrysum umbraculigerum Phytochemistry 18 1979 1371 1374
43. G. Appendino, and et al. Helichrysum italicum: the sleeping giant of Mediterranean herbal medicine HerbalGram 105 2015 34 45
44. A.C. Lourens, and et al. South African Helichrysum species: a review of the traditional uses, biological activity and phytochemistry J. Ethnopharmacol. 119 2008 630 652
45. A.C. Basile, and et al. Anti-inflammatory activity of oleoresin from Brazilian Copaifera J. Ethnopharmacol. 22 1988 101 109
46. Y. Tambe, and et al. Gastric cytoprotection of the non-steroidal anti-inflammatory sesquiterpene, β-caryophyllene Planta Med. 62 1996 469 470
47. J. Gertsch, and et al. Beta-caryophyllene is a dietary cannabinoid Proc. Natl. Acad. Sci. U.S.A. 105 2008 9099 9104
48. 2 receptor action? Commun. Integr. Biol. 1 2008 26 28
49. M. Karsak, and et al. Attenuation of allergic contact dermatitis through the endocannabinoid system Science 316 2007 1494 1497
50. P. Pacher, and R. Mechoulam Is lipid signaling through cannabinoid 2 receptors part of a protective system? Prog. Lipid Res. 50 2011 193 211
51. R. Tisserand, and R. Young Essential Oil Safety 2014 Churchill Livingstone Elsevier
52. 2 and multiple signal transduction pathways FEBS Lett. 577 2004 563 569
53. S. Raduner, and et al. Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects J. Biol. Chem. 281 2006 14192 14206
54. A. Chicca, and et al. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts Int. Immunopharmacol. 9 2009 850 858
55. K. Spelman, and et al. Role for PPARγ in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide Int. Immunopharmacol. 9 2009 1260 1264
56. J. Haller, and et al. The effect of Echinacea preparations in three laboratory tests of anxiety: comparison with chlordiazepoxide Phytother. Res. 24 2010 1605 1613
57. J. Hohmann, and et al. Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors Phytochemistry 72 2011 1848 1853
58. 9-tetrahydrocannabivarin negative modulators of the endocannabinoid system?. A systematic review Br. J. Pharmacol. 172 2015 737 753
59. G. Korte, and et al. Tea catechins' affinity for human cannabinoid receptors Phytomedicine 17 2010 19 22
60. J. Gertsch, and et al. Phytocannabinoids beyond the Cannabis plant-do they exist? Br. J. Pharmacol. 160 2010 523 529
61. L. Thors, and et al. Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids Br. J. Pharmacol. 155 2008 244 252
62. H. Wu, and et al. Macamides and their synthetic analogs: evaluation of in vitro FAAH inhibition Bioorg. Med. Chem. 21 2013 5188 5197
63. V. Di Marzo, and et al. Trick or treat from food endocannabinoids? Nature 396 1998 636 637
64. S. Maurelli, and et al. Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma 'anandamide amidohydrolase' FEBS Lett. 377 1995 82 86
65. C. Rousseaux, and et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors Nat. Med. 13 2007 35 37
66. G. Clarke, and et al. Probiotics for the treatment of irritable bowel syndrome-focus on lactic acid bacteria Aliment. Pharmacol. Ther. 35 2012 403 413
67. 9-tetrahydrocannabinol PLoS ONE 10 2015 e0144270
68. J. Slavin Fiber and prebiotics: mechanisms and health benefits Nutrients 5 2013 1417 1435
69. W. Calame, and et al. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner Br. J. Nutr. 100 2008 1269 1275
70. W.T. Vickers, and T. Plowman Useful plants of the Siona and Secoya Indians of eastern Ecuador Fieldiana 15 1984 1 63
71. K.A. Seely, and et al. The dietary polyphenols trans-resveratrol and curcumin selectively bind human CB1 cannabinoid receptors with nanomolar affinities and function as antagonists/inverse agonists J. Pharmacol. Exp. Ther. 330 2009 31 39
72. P.L. Prather, and et al. Notice of retraction J. Pharmacol. Exp. Ther. 331 2009 1147
73. K.A. da Silva, and et al. Activation of cannabinoid receptors by the pentacyclic triterpene alpha,beta-amyrin inhibits inflammatory and neuropathic persistent pain in mice Pain 152 2011 1872 1887
74. A. Chicca, and et al. The antinociceptive triterpene beta-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors Br. J. Pharmacol. 167 2012 1596 1608
75. A. Moussaieff, and et al. The Jerusalem balsam: from the Franciscan Monastery in the old city of Jerusalem to Martindale 33 J. Ethnopharmacol. 101 2005 16 26
76. A. Moussaieff, and et al. Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain FASEB J. 22 2008 3024 3034
77. A. Moussaieff, and et al. Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii J. Cereb. Blood Flow Metab. 28 2008 1341 1352
78. S. Nicolussi, and et al. Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice Pharmacol. Res. 80 2014 52 65
79. E.B. Russo The endocannabinoid system in health and disease: herbalism for the future. In 26th Annual American Herbalists Guild Symposium 2015 American Herbalists Guild
80. G. Pacioni, and et al. Truffles contain endocannabinoid metabolic enzymes and anandamide Phytochemistry 110 2015 104 110
81. E.B. Blancaflor, and et al. N-Acylethanolamines: lipid metabolites with functions in plant growth and development Plant J. 79 2014 568 583